EUROLAB
fda-21-cfr-61017-stability-testing-of-biological-products
Stability Studies (ICH Guidelines) BP Appendix XVI Stability of Finished Products with PreservativesBP Stability Evaluation of Modified Release PreparationsEMA CHMP/QWP/609/2014 Quality Requirements for Stability of BiosimilarsEMA CPMP/QWP/122/02 Stability Testing for Transdermal PatchesEMA Guideline for Stability of Veterinary Medicinal ProductsEMA Guideline on Holding Times for Bulk Products (Stability Implication)EMA Guideline on Stability Testing for Liposomal Drug FormulationsEMA Guideline on Stability Testing for Orally Inhaled ProductsEMA Reflection Paper on Stability for Polymers in Drug DeliveryEMA Reflection Paper on Stability of Advanced Therapies (ATMPs)EMA Stability Testing for Nanoparticle FormulationsEMA Stability Testing in Pediatric FormulationsEMA Stability Testing of Drug-Device Combination ProductsEP 1.2.1 Drug Substance Stability in Multisource SubmissionsEP 2.9.5 Uniformity of Mass Post-Stability TestingEP 3.2.1 Container Closure System Stability EvaluationEP 5.20 Climatic Conditions in Stability Storage ChambersEP 6.0 Stability Testing Requirements for MonographsEP 6.1 Real-Time Stability Testing of Biological ExtractsEP Climatic Zones IVa and IVb for ASEAN and African MarketsFDA 21 CFR 211.166 Stability Program Requirements for PharmaceuticalsFDA Accelerated Stability Protocol for Veterinary DrugsFDA cGMP Guidelines for Expiration Dating and Stability StudiesFDA Container Closure Stability Evaluation for Ophthalmic ProductsFDA Draft Guidance for Stability of Inhaled Cannabis ProductsFDA Draft Guidance on Cannabis Stability Testing in Drug DevelopmentFDA Guidance for Allergenic Products Stability AssessmentFDA Guidance for Industry: Stability Testing for Nutritional SupplementsFDA Guidance on Freeze-Thaw Stability Testing for BiologicsFDA Post-Approval Changes and Stability RequirementsFDA Q&A Guidance for Stability of Topical Dermatologic ProductsFDA Requirements for Drug Substance Holding Time & StabilityFDA Requirements for Orphan Drugs and Niche Stability StudiesICH E2E Pharmacovigilance & Stability Shelf-life ManagementICH E3 Stability Documentation in Clinical Study ReportsICH E6(R2) GCP Considerations in Clinical Trial Stability SamplesICH M10 Bioanalytical Method Validation in Stability TestingICH M4Q Stability Data Compilation for Common Technical Document (CTD)ICH M9 Stability of Biowaiver-Based Generic SubmissionsICH Q10 Pharmaceutical Quality System and Stability OversightICH Q11 Stability of Drug Substances in Developmental StagesICH Q12 Lifecycle Management and Ongoing Stability MonitoringICH Q14 Analytical Procedure Development in Stability StudiesICH Q1A(R2) Accelerated Stability Testing of Solid Oral Dosage FormsICH Q1B Photostability Testing for Light-Sensitive Drug ProductsICH Q1C Stability Testing for New Dosage Forms (Capsules, Tablets, etc.)ICH Q1D Bracketing and Matrixing Design Stability Protocol DevelopmentICH Q1E Evaluation of Stability Data for Regulatory SubmissionsICH Q1F Stability Data Requirements for Global RegistrationICH Q2(R1) Validation of Analytical Procedures in Stability StudiesICH Q3B(R2) Stability Testing of Impurities in Drug ProductsICH Q3C Residual Solvent Stability in Finished Dosage FormsICH Q4 Guidelines for Pharmacopoeial Stability HarmonizationICH Q4B Annex Stability-Related Harmonization for Global FilingICH Q5C Stability Testing of Biotechnological/Biological ProductsICH Q5D Derivation and Stability of Cell SubstratesICH Q6B Specifications Testing for Biotech Products in Long-Term StudiesICH Q8 Design Space for Stability-Critical ParametersICH Q9 Risk-Based Stability Planning and Protocol DesignICH S3B Photostability of Biologics in Animal StudiesICH S4 Stability of New Veterinary Drug Substances and ProductsICH S6(R1) Preclinical Stability of Biotech ProductsISO 10993-1 Biocompatibility Stability Studies in Medical DevicesISO 11607 Package Integrity Stability for Sterile Medical DevicesISO 13408 Stability Testing of Aseptic Processing SystemsISO 14644 Environmental Monitoring for Stability ChambersISO 14971 Risk Management Related to Stability FailuresISO 15378 GMP for Primary Packaging Stability InteractionsISO 17025 Stability Testing Accreditation RequirementsISO 17034 Reference Material Stability and HomogeneityISO 20387 Stability Assessment in Biobanking Sample StorageISO 21973 Transport Stability of Cell-Based TherapiesISO 9001:2015 Quality System Requirements for Stability ProgramsUSP <1046> Cellular and Gene Therapy Product StabilityUSP <1049> Excipient Stability and Shelf-Life EvaluationUSP <1079> Storage and Stability Testing in Distribution SystemsUSP <1086> Impurities Testing within Stability ProtocolsUSP <1090> Assessment of Drug Product Performance Post StabilityUSP <1118> Monitoring Stability in Storage and Transport ConditionsUSP <1168> Stability Testing for RadiopharmaceuticalsUSP <1191> Stability Considerations in Compounding Pharmacy ProductsUSP <1224> Transfer of Analytical Procedures in Stability StudiesUSP <1225> Validation of Compendial Procedures in Stability ContextUSP <1226> Verification of Compendial Procedures Post-StabilityUSP <671> Stability Testing of Packaging MaterialsUSP <795> Stability Evaluation of Nonsterile PreparationsUSP <797> Stability Testing of Sterile Preparations in CleanroomsWHO Annex 10 Stability Testing of Active Pharmaceutical IngredientsWHO Annex 7 Stability of Reconstituted Lyophilized ProductsWHO Annex 9 Stability for Zoonotic Biological ProductsWHO Good Storage and Distribution Practices for StabilityWHO Guidelines for Stability of DNA and mRNA VaccinesWHO Guidelines on Stability of Combination ARV TherapiesWHO Stability of Monoclonal Antibodies Under Accelerated ConditionsWHO Stability Requirements for Medical Oxygen and InhalersWHO Stability Testing for Pre-Filled Syringes and Auto-InjectorsWHO Temperature Mapping and Qualification of Stability ChambersWHO TRS 1003 Stability Protocols for Combination ProductsWHO TRS 1010 Stability Testing for Vaccines under Cold Chain ConditionsWHO TRS 1019 Stability Testing of Blood and Blood ProductsWHO TRS 953 Climatic Zone-Based Stability Testing for Global MarketsWHO TRS 970 Real-Time Stability Assessment for WHO PrequalificationWHO TRS 992 Long-Term Stability Testing for Herbal Medicinal Products

Comprehensive Guide to FDA 21 CFR 610.17 Stability Testing of Biological Products Laboratory Testing Service Provided by Eurolab

FDA 21 CFR 610.17 Stability Testing of Biological Products is a laboratory testing service that ensures the quality and efficacy of biological products, including vaccines, blood products, and biologics. This comprehensive guide will delve into the standards governing this testing service, providing in-depth information on the legal and regulatory framework surrounding it.

Relevant Standards

The following international and national standards govern FDA 21 CFR 610.17 Stability Testing of Biological Products:

  • ISO 11133:2014: Microbiology of food, water, and animal feeding stuffs - Guidelines on preparation and production of culture media

  • ASTM E2500-09: Standard Guide for Structural Reliability Analysis

  • EN ISO/IEC 17025:2005: General requirements for the competence of testing and calibration laboratories

  • TSE (Turkish Standards Institution) EN ISO/IEC 17025:2005: General requirements for the competence of testing and calibration laboratories

    • Standard Development Organizations

    Standard development organizations, such as the International Organization for Standardization (ISO), the American Society for Testing and Materials (ASTM), and the European Committee for Standardization (CEN), play a crucial role in developing and maintaining these standards.

    Evolution of Standards

    Standards evolve over time to reflect advances in technology, changes in regulatory requirements, and new scientific discoveries. It is essential to stay up-to-date with the latest revisions and updates to ensure compliance.

    Scope and Requirements

    Each standard has a specific scope and set of requirements that must be met. For example:

  • ISO 11133:2014 provides guidelines on preparing and producing culture media.

  • ASTM E2500-09 offers guidance on structural reliability analysis.

  • EN ISO/IEC 17025:2005 outlines the general requirements for testing and calibration laboratories.

    • Compliance Requirements

    Compliance with these standards is mandatory for industries that require FDA 21 CFR 610.17 Stability Testing of Biological Products, including:

  • Pharmaceutical companies

  • Biotechnology firms

  • Medical device manufacturers

  • Research institutions

    • Failure to comply can result in regulatory non-compliance, product recalls, and damage to a companys reputation.

    Why This Test is Needed

    FDA 21 CFR 610.17 Stability Testing of Biological Products is essential for ensuring the quality and efficacy of biological products. These tests help:

  • Verify product stability over time

  • Ensure compliance with regulatory requirements

  • Detect potential safety issues

    • Business and Technical Reasons

    Conducting these tests provides numerous benefits, including:

  • Quality Assurance: Stability testing ensures that products meet specified standards for quality and performance.

  • Regulatory Compliance: Compliance with FDA 21 CFR 610.17 is mandatory for industries requiring biological product testing.

  • Product Safety: These tests help detect potential safety issues, reducing the risk of adverse events.

    • Consequences of Non-Compliance

    Failure to perform these tests can result in:

  • Regulatory non-compliance

  • Product recalls

  • Damage to a companys reputation

  • Financial penalties

    • Industries and Sectors

    The following industries require FDA 21 CFR 610.17 Stability Testing of Biological Products:

  • Pharmaceutical companies

  • Biotechnology firms

  • Medical device manufacturers

  • Research institutions

    • These tests are crucial for ensuring the quality and efficacy of biological products.

    Risk Factors and Safety Implications

    Failure to perform these tests can result in adverse events, product recalls, and financial penalties. It is essential to conduct these tests to ensure product safety and reliability.

    Testing Equipment and Instruments

    The following equipment and instruments are used for conducting FDA 21 CFR 610.17 Stability Testing of Biological Products:

  • Refrigerators: To maintain a consistent temperature range.

  • Freezers: For storing biological samples at extremely low temperatures.

  • Incubators: For maintaining optimal temperature and humidity levels.

    • Testing Environment Requirements

    The testing environment must be controlled to ensure accurate results. This includes:

  • Temperature: Maintaining a consistent temperature range (e.g., 2-8C or -20C).

  • Humidity: Regulating humidity levels to prevent moisture accumulation.

  • Pressure: Ensuring the testing environment is pressurized to prevent contamination.

    • Sample Preparation Procedures

    Biological samples must be prepared and handled according to specific guidelines. This includes:

  • Sample Collection: Collecting biological samples from a validated source.

  • Sample Storage: Storing samples in refrigerators or freezers at specified temperatures.

  • Sample Handling: Handling samples according to strict protocols.

    • Testing Procedures

    The testing procedures for FDA 21 CFR 610.17 Stability Testing of Biological Products include:

  • Microbiological Analysis: Conducting microbiological tests on biological samples.

  • Chemical Analysis: Performing chemical tests on biological samples.

  • Physical Tests: Conducting physical tests, such as viscosity and pH measurements.

    • Perspective on Regulatory Compliance

    Regulatory compliance is a critical aspect of ensuring the quality and efficacy of biological products. Companies must adhere to FDA 21 CFR 610.17 guidelines for stability testing to avoid regulatory non-compliance, product recalls, and damage to their reputation. By following these guidelines, companies can ensure the safety and reliability of their biological products.

    Consequences of Non-Compliance

    Failure to comply with FDA 21 CFR 610.17 guidelines can result in:

  • Regulatory non-compliance

  • Product recalls

  • Damage to a companys reputation

  • Financial penalties

    • Compliance Requirements

    Companies must adhere to the following compliance requirements:

  • Maintain accurate and complete records of stability testing.

  • Conduct regular audits to ensure compliance with regulatory guidelines.

  • Ensure that all personnel involved in stability testing are trained and qualified.

    • Conclusion

    FDA 21 CFR 610.17 Stability Testing of Biological Products is a critical aspect of ensuring the quality and efficacy of biological products. Companies must adhere to regulatory guidelines, conduct regular audits, and maintain accurate records to ensure compliance. By following these guidelines, companies can ensure the safety and reliability of their biological products.

    Perspective on Standard-Related Information

    Standard-related information is essential for ensuring the quality and efficacy of biological products. Companies must stay up-to-date with the latest revisions and updates to standards governing stability testing. This includes:

  • ISO 11133:2014: Microbiology of food, water, and animal feeding stuffs - Guidelines on preparation and production of culture media.

  • ASTM E2500-09: Standard Guide for Structural Reliability Analysis.

  • EN ISO/IEC 17025:2005: General requirements for the competence of testing and calibration laboratories.

    • Conclusion

    In conclusion, standard-related information is critical for ensuring the quality and efficacy of biological products. Companies must adhere to regulatory guidelines, conduct regular audits, and maintain accurate records to ensure compliance. By following these guidelines, companies can ensure the safety and reliability of their biological products.

    Need help or have a question?
    Contact us for prompt assistance and solutions.

    CONTACT US +902127020000

    Latest News

    View all

    Eurolab Successfully Renews ISO 17025 Accreditation

    Read More

    Expanded Cosmetic Safety Testing Portfolio Now Available at Eurolab

    Read More

    Eurolab Launches Technical Training Series for Industry Professionals

    Read More

    JOIN US
    Want to make a difference?

    Careers